Author(s)
Purpose
- Pathology:
Respiratory tract diseases
Immune system diseases
- Disease:
Asthma
Pulmonary Disease, Chronic Obstructive
- Objective:
To measure patients' inhaled corticosteroids (ICS) related side effect perceptions
- Population for intended use:
Adolescent
Adult
Characteristics
- Type of instrument:
Signs and symptoms
- Administration mode:
Self-administered
- Number of items:
ICQ: 57 items
ICQ-SF: 15 items
- Recall/Observation period:
ICQ: The last 14 days
The last 7 days also available
ICQ-SF: The last 2 weeks
Language(s)
- Original language:
Dutch for the Netherlands
English for the UK
[ Developed simultaneously in Dutch and in English for the UK ]
- List of existing translations:
The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.
ICQ - last 14 days
| Afrikaans* | English for Canada* | French for Canada* | Italian for Italy* |
| Czech* | English for South Africa* | French for France* | Polish for Poland* |
| Danish for Denmark | English for the UK* | German for Austria* | Portuguese for Brazil* |
| Dutch for Belgium (Flemish)* | English for the USA* | German for Germany* | Portuguese for Portugal* |
| English for Australia* | French for Belgium* | Hungarian* | Spanish for Spain* |
ICQ - last 7 days
| Afrikaans* | English for South Africa* | German for Austria* | Portuguese for Brazil* |
| Czech* | English for the UK* | German for Germany* | Portuguese for Portugal* |
| Dutch for Belgium (Flemish)* | French for Belgium* | Hungarian* | Spanish for Spain* |
| English for Australia* | French for Canada* | Italian for Italy* | |
| English for Canada* | French for France* | Polish for Poland* |
* Performed by the MAPI Institute
Note: The author has selected MAPI Institute as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please contact our Information Unit.
Bibliographic reference(s) of the original questionnaire
Foster JM, Aucott L, van der Werf RH, van der Meijden MJ, Schraa G, Postma DS, van der Molen T. Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.Respir Med. 2006 Aug;100(8):1318-36 (PubMed abstract)
Foster JM. Development and validation of the Inhaled Corticosteroid Questionnaire - a model for the measurement of patient-perveived side effects by self-report. Thesis University of Groningen. 2007
Foster, J, van Sonderen, E, Lee, A et al. A self-rating scale for patient-perceived side effects of inhaled corticosteroids. Respir Res. 2006; 7(1): 131-145 (Full text article)
Last update: April 2012
Last update in collaboration with the author: May 2011
Distributed by MAPI Research Trust : ICQ (Inhaled corticosteroid Questionnaire Long Form) and ICQ-SF (Inhaled corticosteroid Questionnaire Short Form)
Developed in 2006 for the ICQ and in 2010 for the ICQ-SF